# DOXIL

NDC: 0338-0067
Generic name: doxorubicin hydrochloride
Labeler / Manufacturer: Baxter Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SUSPENSION, LIPOSOMAL
Routes: INTRAVITREAL
Marketing started: 20190813

FDA application: NDA050718

## Active ingredients

- DOXORUBICIN HYDROCHLORIDE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-0067"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-0067
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce